Over the last approximately 20 years, the pharmaceutical industry has increasingly outsourced its research and development activities, including pharmacovigilance, with mixed results.
This article, co-authored by Brian Edwards, explains the importance for both clients and service providers to understand and openly discuss each other’s needs to avoid the unrealistic expectations often elicited prior to signing a contract.
